NCT00154076View on ClinicalTrials.gov

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

December 31, 2008

Conditions

Epilepsy

Interventions

DRUG

Zonisamide

Initial dose is 100mg/day, increase after 2 weeks to 200mg/day. The maximum dose is 600mg/day.

DRUG

Topiramate

Initial dose is 25mg/day, increase every 1 week to 100mg/day. The maximum dose is 400mg/day.

Trial Locations (1)

Unknown

Daegu Catholic University Medical Center, Daegu

All Listed Sponsors

lead

Eisai Korea Inc.

INDUSTRY

NCT00154076 - A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies | Biotech Hunter | Biotech Hunter